Nexeon Medsystems Inc (NXNN) financial statements (2021 and earlier)

Company profile

Business Address 1910 PACIFIC AVENUE, SUITE 20000
DALLAS, TX 75201
State of Incorp. NV
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments126342347884765211612
Cash and cash equivalents126342347884765211612
Receivables2,5301,5331,8591,8781,8631,535734
Inventory, net of allowances, customer advances and progress billings2,4212,1562,3352,2072,349  
Inventory2,4212,1562,3352,2072,349  
Other current assets107106109158546986
Other undisclosed current assets 1,1838148041,037  
Total current assets:5,1835,3205,4655,9306,0671,8151,433
Noncurrent Assets
Property, plant and equipment3,4493,5063,5423,5701,72711
Intangible assets, net (including goodwill)9,83410,13510,436 9,4348,2308,489
Intangible assets, net (excluding goodwill)9,83410,13510,436 9,4348,2308,489
Other undisclosed noncurrent assets11211211210,852112111111
Total noncurrent assets:13,39513,75414,09014,42111,2738,3428,601
TOTAL ASSETS:18,57819,07419,55520,35117,34010,15710,033
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,4673,8753,1323,0792,405132239
Accounts payable2,8232,4442,3182,5751,992119191
Accrued liabilities1,5591,3567375044091046
Interest and dividends payable867578 332
Debt1,6741,4841,4608665371818
Due to related parties    127  
Deferred tax liabilities401181251174138  
Other undisclosed current liabilities5695695731,01458910 
Total current liabilities:7,1116,1095,4175,1343,795159257
Noncurrent Liabilities
Long-term debt and lease obligation2,328      
Long-term debt, excluding current maturities2,328      
Liabilities, other than long-term debt      10
Due to related parties      10
Other undisclosed noncurrent liabilities 2,5872,9663,3493,664  
Total noncurrent liabilities:2,3282,5872,9663,3493,664 10
Total liabilities:9,4398,6958,3838,4827,459159267
Stockholders' equity
Stockholders' equity attributable to parent, including:9,13910,37911,17211,8699,8829,9979,766
Common stock222828272622
Common stock, value, subscriptions    24  
Additional paid in capital15,83915,74315,67815,49814,84413,8889,669
Accumulated other comprehensive income (loss)43(14)202142  
Accumulated deficit(6,811)(5,419)(4,693)(3,743)(5,157)(4,018)(2,995)
Other additional capital     1013,070
Other undisclosed stockholders' equity attributable to parent666614066101  
Total stockholders' equity:9,13910,37911,17211,8699,8829,9979,766
TOTAL LIABILITIES AND EQUITY:18,57819,07419,55520,35117,34010,15710,033

Income statement (P&L) ($ in thousands)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
Revenues1,9782,8192,8702,1551,040  
Cost of revenue(1,384)(2,819)(2,870)(1,584)(709)  
Cost of goods and services sold (2,016)(1,827)(1,584)(709)  
Other undisclosed gross profit 8041,043    
Gross profit:5938041,043571330  
Operating expenses(1,912)(2,252)(1,844)(1,387)(978)(1,126)(1,368)
Other undisclosed operating loss   (1,283)(287)  
Operating loss:(1,319)(1,448)(800)(2,099)(935)(1,126)(1,368)
Nonoperating income (expense) 160 (74)(89)89 
Investment income, nonoperating 160 (74)   
Foreign currency transaction gain (loss), before tax    (89)89 
Interest and debt expense(78)(76)(82)(82)(27)(1)(1)
Loss from continuing operations before equity method investments, income taxes:(1,397)(1,364)(882)(2,255)(1,052)(1,038)(1,369)
Other undisclosed income (loss) from continuing operations before income taxes   3,68262715(33)
Income (loss) from continuing operations before income taxes:(1,397)(1,364)(882)1,426(424)(1,024)(1,402)
Income tax expense (benefit)6638(68)    
Other undisclosed loss from continuing operations   (13)   
Net income (loss) available to common stockholders, diluted:(1,392)(726)(950)1,413(424)(1,024)(1,402)

Comprehensive Income ($ in thousands)

9/30/2018
Q3
6/30/2018
Q2
3/31/2018
Q1
12/31/2017
Q4
9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
Net income (loss):(1,392)(726)(950)1,413(424)(1,024)(1,402)
Comprehensive income (loss):(1,392)(726)(950)1,413(424)(1,024)(1,402)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent57(34)(1)(21)(81)  
Comprehensive income (loss), net of tax, attributable to parent:(1,335)(760)(951)1,392(506)(1,024)(1,402)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: